Explore more publications!

Africa Daily Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa Daily Journal.

Press releases published on November 7, 2025

LIFE Delivers Lifesaving Medical Aid to Over 15,000 People in Sub-Saharan Africa
Knowledge Networks Joins ECOSOCC Pre-G20 Dialogue to Advance Inclusive AI Governance ahead of Johannesburg
Summit Royalties Announces Appointment of Jerrold Annett as Chairman; Trading to Commence on Venture Exchange; Other Corporate Updates
GFG Closes Final Tranche of Financing
Maxus Mining Announces Closing of Flow Through Private Placement
Replimune Presents Late-Breaking Abstract and Additional Posters on RP1 at 40th Annual Meeting of the Society for the Immunotherapy of Cancer (SITC 2025)
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Taseko to Release Third Quarter 2025 Results
Lithium Argentina to Release PPG Scoping Study Results with Third Quarter 2025 Earnings
InflaRx to Announce Topline Data from Phase 2a Clinical Trial of INF904 in Hidradenitis Suppurativa and Chronic Spontaneous Urticaria
Vapers Misled? Scientists Say Puff Counts Don’t Mean What You Think
XS.com conquista duas vitórias no Dubai Affiliate Summit: Melhor Programa de Afiliados e Melhor Suporte
ADARx Pharmaceuticals Announces Positive Interim Phase 1 Clinical Data for its Novel siRNA Targeting Complement Factor B (CFB)
T-knife Therapeutics Presents Preclinical Data on PRAME-Targeted TK-6302 Highlighting its Potential as a Promising, Category-leading Therapy at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
BioAge Labs to Present at Jefferies Global Healthcare Conference in London
Trained Therapeutix Demonstrates RIDE-001 Trains Myeloid Cells for Anti-Tumor Immune Response in Preclinical Data Presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
Neurogastrx Announces NG101 Phase 2 Clinical Study Demonstrating Significant Reductions in Nausea and Vomiting Induced by GLP-1 Receptor Agonist Semaglutide
Altimmune Presents AI-Based Analysis of Liver Fibrosis Reduction from IMPACT Phase 2b Trial of Pemvidutide in MASH in Late-breaking Poster at AASLD The Liver Meeting® 2025
Celldex to Present at Upcoming Investor Conferences
Rivus Pharmaceuticals Announces New Data from Phase 2 M-ACCEL Trial of HU6 in MASH in Late-Breaker Oral Presentation at AASLD The Liver Meeting® 2025

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions